Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Neoplasms 19Colorectal Neoplasms 19Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Solid Cancers × Clear all
NCT07510841 2026-04-06

JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

Biotech Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
228 enrolled

Solid Cancers

NCT07030478 2025-06-22

A Study to Evaluate the Safety and Tolerability of EP0089

Ellipses Pharma

Phase 1/2 Not yet recruiting
190 enrolled
Other solid neoplasm

Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡